Recruiting

Latanoprost vs. Timolol

Sponsor:

Intuor Technologies, Inc.

Code:

NCT04178863

Conditions

Glaucoma; Drugs

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Interventions

CATS Tonometer

Latanoprost

Study Details

Brief summary:

Topical Prostaglandin Analog vs Betablocker - Corneal Biomechanical Evaluation using CATS Tonometer Prism

Conditions

Glaucoma; Drugs

Study ID

NCT04178863

Start date

Jul 1, 2018

Status verified date

Nov, 2019

Completion date

Dec 30, 2019

Anticipated

Primary completion date

Dec 30, 2019

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • • Male and female patients, at least 18 years of age

  • Subject has a clear understanding and agrees to all the conditions of the informed consent form

Exclusion Criteria:

  • Subjects shall be selected in accordance with the following exclusion criteria

  • Subject has undergone ocular surgery within the last 3 months
  • Uncontrolled systemic disease that in the opinion of the Investigator would put the subject's heath at risk
  • Pregnant or nursing women
  • Those who have had corneal surgery including corneal laser surgery
  • Microphthalmos
  • Buphthalmos
  • Severe Dry eyes
  • Lid squeezers - blepharospasm
  • Nystagmus
  • corneal or conjunctival infection.

Study Design

Enrollment

72 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Diagnostic

Interventions and Outcome Measures

Arms

active comparator: lataprost

latanoprost use

active comparator: timolol

timolol group

Interventions

CATS Tonometer

latanoprost vs. timolol

Latanoprost

latanoprost IOP reduction

Primary outcome measure

  • IOP reduction [ Time Frame: 1 month ]

Central Contacts and Locations

Locations

Arizona Eye Consultants

Recruiting

Tucson, Arizona, United States, 85710

Contacts

Sean McCafferty, MD

520-400-4255sjmccafferty66@hotmail.com

More Information

Sponsor

Intuor Technologies, Inc.

Last update posted

Nov 26, 2019

Last verified

Nov, 2019

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Intuor Technologies, Inc. on 2019-11-26.